Should hydrogen therapy be included in a musculoskeletal medicine routine?

Abstract

Molecular hydrogen (H 2) has recently been recognized as a potential novel therapeutic agent in biomedicine. Initially proposed to be a possible treatment for certain types of neuromuscular disorders, cardio-metabolic diseases and cancer, H 2 improved clinical end-points and surrogate markers in several clinical trials, mainly acting as an anti-inflammatory agent and powerful antioxidant. In this paper, the medicinal properties of H 2 in musculoskeletal medicine are discussed with the aim to provide an updated and practical overview for health professionals working in this field.

• Authors: Sergej M Ostojic
• Journal: F1000Research (F1000Res) Vol. 5 Pg. 2659 ( 2016) ISSN: 2046-1402 [Print] England
• PMID: 28003879 (Publication Type: Journal Article)